Icahn School Of Medicine At Mount Sinai

  • ConduITS Institute for Translational Sciences at the Icahn School of Medicine at Mount Sinai

    The mission of the ISMMS CTSA, ConduITS, is to streamline and centralize the infrastructure needed to accelerate translational research across an ever expanding research enterprise; foster team science responsive to emerging theories, technologies, and data science challenges; innovate processes to increase the quality and efficiency of translational research; develop informatics tools and solutions to accelerate the full translational continuum; and develop innovative educational programs training the workforce needed to respond to the challenges of 21st Century translational science.
  • Cruz Poster
    Icahn School Of Medicine At Mount Sinai

    The Integrating CTS into the CTSA Virtual Visiting Scholar Program Working Group is pleased to announce a Grand Rounds Lecture. Please join us on Tuesday, June 13, 2023 at 12:30pm ET. Christina Cruz, MD, Assistant Professor, Division of Child and Adolescent Psychiatry, University of North Carolina, will present: Teachers Delivering and Supporting Indicated Mental Health Care in Schools Click here

  • Clinical Climate Change Conference
    Icahn School Of Medicine At Mount Sinai

    The 4th Clinical Climate Change conference will be held on Friday, January 7 virtually. A zoom session with judges will be held Thursday, January 6. Students and trainees can register for free! This CME conference is aimed at a broad audience of allied health professionals and researchers seeking to understand the impacts of climate change on human health and improve patient outcomes. This year’s

  • Icahn logo
    Icahn School Of Medicine At Mount Sinai

    Diane Chan, MD, PhD, visiting KL2 scholar from Harvard Medical School will be presenting her research on "Gamma Frequency Neural Oscillations Using Sensory Stimulation to Treat Alzheimer’s Disease".

  • Urea Cycle Disorders Consortium

    Urea cycle disorders (UCDs) are rare but devastating genetic conditions. In 2003, the Urea Cycle Disorders Consortium (UCDC) became one of the first members of the RDCRN. Since then, UCDC has flourished into an international network of 16 academic centers in the United States, Canada and Europe that provide state-of-the-art care and conduct cutting-edge clinical research. The UCDC is currently

  • Porphyrias Consortium (PC)

    The porphyrias are a group of rare, inherited disorders, each caused by a deficiency with one of eight enzymes necessary to produce heme, an important component of hemoglobin and other proteins. The porphyrias are classified as either acute hepatic (liver) or cutaneous (skin); the former is characterized generally by acute attacks of severe abdominal pain accompanied by nausea, vomiting and other

  • Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)

    Eosinophilic esophagitis, eosinophilic gastritis, eosinophilic gastroenteritis, and eosinophilic colitis are disorders in which a type of immune cell (called eosinophils) builds up in the digestive tract, causing gastrointestinal tissue damage. These disorders are painful, lifelong, and make it hard or impossible for people to eat many or all foods. The Consortium of Eosinophilic Gastrointestinal

  • Icahn School Of Medicine At Mount Sinai

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting coronavirus disease 2019 (COVID-19) have stretched healthcare systems thin across the world. During a COVID-19 surge, local academic medical centers must both care for the ill and perform research to better understand the pathogenicity of this disease. Here, we provide an account of a 49-day period during which we built

    Autism spectrum disorder (ASD) affects 1 in 59 children in the United States and is a major public health concern and challenge. The Developmental Synaptopathies Consortium (DSC) aims to explore the underlying causes of autism by focusing on three rare genetic disorders related to ASD, including Tuberous Sclerosis Complex (TSC), PTEN Hamartoma Tumor Syndrome (PHTS) and Phelan-McDermid Syndrome
  • Drawing of a network on a global

    The New York and Connecticut Consortium encourages joint ventures among the New York and Connecticut area CTSA institutions (NYCON) to develop collaboration between CTSA programs in the areas of medical scientist training; the creation of regional databases of facilities; regional training opportunities for investigators and research coordinators; the exploration of barriers to improved social